Remimazolam in Cardiac Anesthesia: Analysis of Recent Data
Journal of Cardiothoracic and Vascular Anesthesia · 2025-01 · 39 (1) · 273-285
DOI: 10.1053/j.jvca.2024.08.030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiothoracic and Vascular Anesthesia, 2025-01. Verfasst von Juan G Ripoll und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN. Hauptthemen laut MEDLINE: Benzodiazepines, Anesthesia, Cardiac Procedures. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Interest in remimazolam has surged in recent years, thanks to its advantageous pharmacologic profile. This ultra-short-acting benzodiazepine is noted for its rapid onset and termination of action, organ-independent elimination, availability of a reversal agent, and excellent hemodynamic stability. Although the use of remimazolam has been explored in various anesthesia settings and procedures, data on its application in cardiovascular anesthesia and catheterization laboratory procedures remain limited. This review evaluates the latest literature to assess remimazolam's role in cardiovascular anesthesia across different settings and procedures. The analysis shows that remimazolam offers anesthesia without significant hemodynamic instability and a reduced need for vasopressors, with an incidence of perioperative adverse events comparable to that of other agents. These findings are relevant for both the induction and maintenance of general anesthesia in catheterization laboratory procedures and general anesthesia in elective cardiac surgery. Although further research is needed to fully understand remimazolam's role in cardiovascular anesthesia, its favorable hemodynamic and safety profile suggests that it is a promising option for cardiac anesthesiologists in both the catheterization laboratory and the operating room.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN.
- Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA.
- Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN. Electronic address: ramakrishna.harish@mayo.edu.
Zitieren
APA
Ripoll, J. G., Orjuela, R. B., Kanaparthi, A., Diaz Soto, J. C., ElSaban, M. A., Peclat, T. R., Wieruszewski, P. M., Abcejo, A. S., Chang, M. G., Bittner, E. A., & Ramakrishna, H. (2025). Remimazolam in Cardiac Anesthesia: Analysis of Recent Data. Journal of Cardiothoracic and Vascular Anesthesia, 39(1), 273-285. https://doi.org/10.1053/j.jvca.2024.08.030
Vancouver
Ripoll JG, Orjuela RB, Kanaparthi A, Diaz Soto JC, ElSaban MA, Peclat TR, et al. Remimazolam in Cardiac Anesthesia: Analysis of Recent Data. Journal of Cardiothoracic and Vascular Anesthesia. 2025;39(1):273-285. doi:10.1053/j.jvca.2024.08.030
BibTeX
@article{Ripoll2025,
author = {Ripoll, Juan G and Orjuela, Rayssa Becerra and Kanaparthi, Anuradha and Diaz Soto, Juan C and ElSaban, Mariam A and Peclat, Thais R and Wieruszewski, Patrick M and Abcejo, Arnoley S and Chang, Marvin G and Bittner, Edward A and Ramakrishna, Harish},
title = {Remimazolam in Cardiac Anesthesia: Analysis of Recent Data},
journal = {Journal of Cardiothoracic and Vascular Anesthesia},
year = {2025},
volume = {39},
number = {1},
pages = {273--285},
doi = {10.1053/j.jvca.2024.08.030}
}
EUVIMED